Intelligence · Clinical Development
Pipeline search results
Programs matching “pregabalin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 15 pipeline programs matching "pregabalin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Pregabalin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Herpetic Neuralgia
1 trial -
Pregabalin Dose Level 1
Pfizer
Partial Onset Seizures
1 trial -
pregabalin
Pfizer
Neuropathy
1 trial -
pregabalin
Pfizer
Partial Seizures
2 trials -
KETOROLAC, PREGABALIN
The George Institute
Estrogen receptor-positive early breast cancer (ER + BC).
1 trial -
Pregabalin
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Neuropathic Pain
1 trial -
pregabalin
United Therapeutics Europe Ltd
Pain
1 trial -
37.5mg Pregabalin + 75mg Pregabalin
The First People's Hospital of Lianyungang
Pain, Postoperative
1 trial -
Pregabalin
Pfizer
Bone Neoplasms
1 trial -
Pregabalin
Vera Therapeutics
Pain, Postoperative
1 trial -
Pregabalin
Yung NA
Diabetic Peripheral Neuropathy
1 trial -
pregabalin
Pfizer
Diabetic Neuropathy, Painful
1 trial -
pregabalin and celecoxib
Pfizer
Chronic Low Back Pain With a Neuropathic Component
1 trial -
Pregabalin
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.